Clinical Genetics · Cleveland, OH
NPI
1699783316
Since 2006
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2500 Metrohealth Dr
Cleveland, OH, 44109
Phone (216) 778-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,063
80 services
Medicare patients, 2024
71
Average age 68
Drug cost, 2024
$2.0M
26 prescriptions
Company payments, 2025
$61
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rocio T Moran was code 99443 (telephone services), 53 times for 48 patients. In total Rocio T Moran billed 80 services in 9 codes, and Medicare paid $5,063.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99443 Telephone Services | Facility | 53 | 48 | $65.09 | $3,450 |
By year: 2022 $3,822 for 67 services; 2023 $3,723 for 60 services; 2024 $5,063 for 80 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rocio T Moran prescribed most often to Medicare patients was Vimizim (Elosulfase Alfa), with 12 prescriptions and refills. In total Rocio T Moran wrote 26 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vimizim Elosulfase Alfa | 12 | 12 | Under 11 | $1.6M |
Brand drugs: 24 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rocio T Moran $61 ($61 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $61.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 3 | $61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.